RENOVA, Inc | Creating our future with renewable energy. Toward a sustainable future. This is Renova’s commitment for 2030. Renova will continue to move forward with this mid-term management plan as a solid foundation. RENOVA Solutions © 2026 RENOVA Solutions, Corp. At Renova, our passion extends beyond creating clothing; we craft styles that reflect individuality, confidence, and the spirit of NYC. Established in 2015, we’re committed to designing men’s and women’s apparel that merges classic elegance with modern trends. RenovoRx is a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared local drug-delivery device, targeting high unmet medical needs. Renova is an European brand of high quality and innovative products. Available in more than 60 countries worldwide, it offers colourful designs and new functional solutions through stylish and environmentally happy products. Renova is a European brand of high quality and innovative tissue products for Personal Care, Domestic and Professional Hygiene. Renova offers colourful designs and new functional solutions through stylish and environmentally happy products for the home and body. We are committed to delivering customized solutions, exceptional customer service, and superior American craftsmanship that ensures faster and more efficient lighting installations for institutional, commercial, healthcare, and industrial markets. Renova Environmental Company is an employee-owned and small, minority business enterprise (SBE/MBE), with core competencies as a self-performing environmental remediation, restoration and heavy civil construction firm supporting our clients since 2006. RENOVA moves everything else. Connect HR, payroll, time, and talent in one flexible platform that turns complex tasks into simple decisions. Spend less time on payroll & HR. More time on your business. ONE PLATFORM. YOUR WHOLE TEAM. Less administration. More human impact. RenovoCath is FDA-cleared for targeted delivery of chemotherapy to selected sites in the peripheral vascular system. The company is studying the use of RenovoCath-delivered gemcitabine for treatment of Locally Advanced Pancreatic Cancer (LAPC) in an ongoing clinical trial conducted under an IND. © 2026 RenovoRx®. All rights reserved.